ReviewClinical reviews in allergy & immunology2026
Molecular Signature and miRNA Pattern of CD4 + T Lymphocytes in Plaque Psoriasis.
Review in Clinical reviews in allergy & immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Psoriasis is a global health problem affecting approximately 3% of the population. Because this autoimmune and autoinflammatory disease significantly reduces the quality of life and carries the risk of serious complications and comorbidities, all efforts have been directed towards developing effective therapeutic strategies that allow for a significant restoration of immunological homeostasis. To make this possible, basic research is being conducted, among others, to discover the molecular basis responsible for the pathogenic activation of autoreactive lymphocytes. At the same time, microRNAs seem to be very interesting candidates for epigenetic modulation of signaling pathways disturbed in psoriasis, which are themselves also affected in its pathogenesis. Therefore, our narrative review comprehensively summarizes the current knowledge on the molecular signature and miRNA profile that appear characteristic for psoriasis-related CD4 + T lymphocytes and hypothesizes the effects of microRNA dysregulation based on the results of a contextual functional analysis of selected candidates having the greatest impact on the pathogenesis of psoriasis. Detailed considerations allowed us to uncover the most important signaling pathways and microRNA molecules active in pathogenic CD4 + T lymphocytes that are involved in psoriasis progression, and also suggested other microRNAs that appear to have potential therapeutic activity, with the leading opposing roles of interferon regulatory factor 4, microRNA-155 and microRNA-150.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.